Clinical Trial Update: A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 randomized platform trial investigating treatments for metastatic hormone-sensitive prostate cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer

Snippet

Sponsor: University College, London | Conditions: Prostate Cancer Metastatic | Phase 3 | Status: RECRUITING